COGENT BIOSCIENCES INC
COGT
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Cogent Biosciences is a clinical-stage biotechnology company developing targeted therapies for genetically defined diseases. Its drug discovery and development pipeline relies on preclinical animal testing to assess safety and efficacy, as documented in its SEC filings. The company’s research activities are conducted under the Animal Welfare Act.
In March 2023, regulatory filings noted that some required preclinical testing, such as longer-term toxicity studies and tests for reproductive adverse events, may continue to require animal models. The company's operations are subject to regulations governing animal research. While the U.S. FDA has published a roadmap to reduce animal testing in preclinical studies, the use of animals remains a standard component of the biopharmaceutical development process for companies like Cogent Biosciences.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.